Teva Pharmaceutical Industries Ltd. got the OK to market and distribute Cel-Sci Corp.'s cancer drug Multikine in Israel and Turkey.
Once the drug has been approved, Vienna-based Cel-Sci (AMEX:CVM) will make the product, while the Israel-based generic pharmaceutical giant will be responsible for sales. Revenue will be split evenly between both companies.
Health & Wellness
|
| ©SPL |
| NICE advises on which drugs should be bought by the NHS |
The head of a government health advisory body has accused pharmaceutical companies of driving up the price of medicine.
Professor Sir Michael Rawlins says drugs are expensive because of "perverse incentives" in the pharmaceutical industry.
The chairman of the National Institute for Clinical Excellence (NICE) made his comments to the Observer newspaper.
NICE has recently been criticised for failing to approve kidney cancer drugs.
Soon, those drug-branded pens, clipboards and coffee mugs will be a thing of the past in physicians offices.
The nation's largest pharmaceutical trade association now says its members can no longer hand out those trinkets and freebies, and it sharply curtailed when, where and how drug companies can wine and dine physicians.
The new code of conduct, which goes into effect Jan. 1, was designed to squelch, once and for all, any negative perceptions that doctors are influenced by or make prescribing choices as a result of gifts from drug manufacturers.
The nation's largest pharmaceutical trade association now says its members can no longer hand out those trinkets and freebies, and it sharply curtailed when, where and how drug companies can wine and dine physicians.
The new code of conduct, which goes into effect Jan. 1, was designed to squelch, once and for all, any negative perceptions that doctors are influenced by or make prescribing choices as a result of gifts from drug manufacturers.
People have long prized silver as a precious metal. Now, silver-coated endotracheal tubes are giving critically ill patients another reason to value the lustrous metal. Researchers at Washington University School of Medicine in St. Louis and the NASCENT Investigation Group, report that the silver-coated tubes led to a 36 percent reduction of ventilator-associated pneumonia (VAP).
Jackie Reid doesn't have much faith in new research that shows many people who have contracted West Nile virus from infected mosquitoes will fully recover.
Her 67-year-old husband, Ron, contracted the virus in 2002 from a mosquito bite while in Toronto. It soon developed into a neurological condition - encephalitis, a swelling of the brain. Six years later, the city man still requires around-the-clock care.
Her 67-year-old husband, Ron, contracted the virus in 2002 from a mosquito bite while in Toronto. It soon developed into a neurological condition - encephalitis, a swelling of the brain. Six years later, the city man still requires around-the-clock care.
Singapore - Women are their own workplace enemies when it comes to cracking the glass ceiling, with an international study finding they are less likely to promote themselves and network than their male counterparts.
The 2008 study, part of U.S. behavioral scientist Shannon L. Goodson's new book The Psychology of Sales Call Reluctance, compared almost 11,500 professional women with 16,700 men from 34 countries.
The 2008 study, part of U.S. behavioral scientist Shannon L. Goodson's new book The Psychology of Sales Call Reluctance, compared almost 11,500 professional women with 16,700 men from 34 countries.
You may think you know that person over in the next cubicle. You know what position his kid plays on his Little League team. You know he makes a mean guacamole for the company picnic. And you know he always remembers to send his wife flowers on her birthday.
At least 110 people have now been affected by an outbreak of norovirus in a Cornish seaside village.
A female veterinarian who euthanased a racehorse infected with the potentially deadly Hendra virus has a nervous wait to be cleared of the virus after a needlestick injury.
Scientists and consumers have known for years that grapefruit juice can increase the absorption of certain drugs - with the potential for turning normal doses into toxic overdoses. Now, the researcher who first identified this interaction is reporting new evidence that grapefruit and other common fruit juices, including orange and apple, can do the opposite effect by substantially decreasing the absorption of other drugs, potentially wiping out their beneficial effects.
The study provides a new reason to avoid drinking grapefruit juice and these other juices when taking certain drugs, including some that are prescribed for fighting life-threatening conditions such as heart disease, cancer, organ-transplant rejection, and infection, the researcher says. These findings - representing the first controlled human studies of this type of drug-lowering interaction - were described today at the 236th National Meeting of the American Chemical Society.
"Recently, we discovered that grapefruit and these other fruit juices substantially decrease the oral absorption of certain drugs undergoing intestinal uptake transport," says study leader David G. Bailey, Ph.D., a professor of clinical pharmacology with the University of Western Ontario in London, Ontario. "The concern is loss of benefit of medications essential for the treatment of serious medical conditions."
|
| ©The Florida Department of Citrus |
The study provides a new reason to avoid drinking grapefruit juice and these other juices when taking certain drugs, including some that are prescribed for fighting life-threatening conditions such as heart disease, cancer, organ-transplant rejection, and infection, the researcher says. These findings - representing the first controlled human studies of this type of drug-lowering interaction - were described today at the 236th National Meeting of the American Chemical Society.
"Recently, we discovered that grapefruit and these other fruit juices substantially decrease the oral absorption of certain drugs undergoing intestinal uptake transport," says study leader David G. Bailey, Ph.D., a professor of clinical pharmacology with the University of Western Ontario in London, Ontario. "The concern is loss of benefit of medications essential for the treatment of serious medical conditions."
